1. Losik DV, Nikitin NA, Minin SM, Fisher EV, Mikheenko IL, Chernyavskiy AM, Romanov AB. Relationship between epicardial adipose tissue and prognosis of cardiovascular events. Kardiologiya i Serdechno-Sosudistaya Khirurgiya. 2021;14(4):253 258. doi:10.17116/kardio202114041253 (In Russian)
2. Villasante Fricke A.C., Iacobellis G. Epicardial Adipose Tissue: Clinical Biomarker of Cardio-Metabolic Risk. International Journal of Molecular Sciences. 2019;20(23):5989. doi: 10.3390/ijms20235989.
3. Rashidova M.A. , Darenskaya M.A., Kolesnikova L.I. The role of some cytokines (IL-1, IL-6, IL-18, IL-22, TNF-Α) in the genesis of obesity. Modern problems of science and education. 2022; 6(2):42. doi:10.17513/spno.32339 (In Russian)
4. Li Y., Liu B., Li Y., Jing X., Deng S., Yan Y., She Q. Epicardial fat tissue in patients with diabetes mellitus: a systematic review and meta-analysis. Cardiovasc Diabetology. 2019; 18(1):3. doi: 10.1186/s12933-019-0807-3.
5. Ott A.V., Chumakova G.A. Epicardial obesity as one of the basic criteria for metabolically unhealthy obesity phenotype and the predictor of subclinical atherosclerosis. Complex Issues of Cardiovascular Diseases. 2018;7(1):21-28. doi: 10.17802/2306- 1278-2018-7-1-21-28 (In Russ.)
6. Chumakova G.A., Kuznetsova T.Yu., Druzhilov M.A., Veselovskaya N.G. Visceral adiposity as a global factor of cardiovascular risk. Russian Journal of Cardiology. 2018;(5):7-14. doi: 10.15829/1560-4071-2018-5-7-14 (In Russian)
7. Mustafina I.A., Ionin V.A., Dolganov A.A., Ishmetov V.Sh., Pushkareva A.E., Yagudin T.A., Danilko K.V., Zagidullin N.Sh. Role of epicardial adipose tissue in the development of cardiovascular diseases. Russian Journal of Cardiology. 2022;27(1S):4872. doi:10.15829/1560-4071-2022-4872 (In Russian)
8. Chen Q., Wu Y., Gao Y., Zhang Z., Shi T., Yan B. Effect of visceral adipose tissue mass on coronary artery disease and heart failure: A Mendelian randomization study. Int J Obes (Lond). 2022;46(12):2102-2106. doi: 10.1038/s41366-022-01216-x.
9. Lawton J.S., Tamis-Holland J.E., Bangalore S., Bates E.R., Beckie T.M., Bischoff J.M., Bittl J.A., Cohen M.G., DiMaio J.M., Don C.W., Fremes S.E., Gaudino M.F., Goldberger Z.D., Grant M.C., Jaswal J.B., Kurlansky P.A., Mehran R., Metkus T.S. Jr., Nnacheta L.C., Rao S.V., Sellke F.W., Sharma G., Yong C.M., Zwischenberger B.A. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2022;79(2):e21-e129. doi: 10.1016/j.jacc.2021.09.006.
10. Boytsov S.A., Pogosova N.V., Ansheles A.A., Badtieva V.A., Balakhonova T.V., Barbarash O.L., Vasyuk Yu.A., Gambaryan N.G., Gendlin G.E., Golitsyn S.P., Drapkina O.M., Drozdova L.Yu., Yezhov M.V., Ershova A.I., Zhirov I.V., Karpov Yu.A., Kobalava Zh.D., Kontsevaya A.V., Litvin A.Yu., Lukyanov M.M., Martsevich S.Yu., Matskeplishvili S.T., Metelskaya V.A., Meshkov A.N., Mishina I.E., Panchenko E.P., Popova A.B., Sergienko I.V., Smirnova M.D., Smirnova M.I., Sokolova O.Yu., Starodubova A.V., Sukhareva O.Yu., Ternovoy S.K., Tkacheva O.N., Shalnova S.A., Shestakova M.V. Cardiovascular prevention 2022. Russian national guidelines. Russian Journal of Cardiology. 2023;28(5):5452. doi:10.15829/1560-4071-2023-5452. (In Russian)
11. Walldius G., Jungner I. Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy. Journal of Internal Medicine. 2004; 255: 188–205. doi: 10.1046/j.1365-2796.2003.01276.x.
12. Carnevale Schianca G.P., Pedrazzoli R., Onolfo S., Colli E., Cornetti E., Bergamasco L., Fra G.P., Bartoli E. ApoB/apoA-I ratio is better than LDL-C in detecting cardiovascular risk.
13. Nutrition Metabolism and Cardiovascular Diseases. 2011; 21: 406–11. doi: 10.1016/j.numecd.2009.11.002.
14. Iacobellis G., Assael F., Ribaudo M.C. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obesity Research. 2003; 11: 304-10. doi: 10.1038/oby.2003.45.
15. Iacobellis G., H.J. Willens H.J. Echocardiographic epicardial fat: a review of research and clinical applications. Journal of the American Society of Echocardiography. 2009; 22: 1311-9. doi: 10.1016/j.echo.2009.10.013.
16. Schejbal V. Epicardial fatty tissue of the right ventricle-morphology, morphometry and functional significance. Pneumologie. 1989; 43(9): 490-9.
17. Kuznetsova T.Yu., Chumakova G.A., Druzhilov M.A., Veselovskaya N.G. Clinical application of quantitative echocardiographic assessment of epicardial fat tissue in obesity. Russian Journal of Cardiology. 2017;(4):81-87. doi:10.15829/1560-4071-2017-4-81-87 (In Russian)
18. Barbu E., Popescu M.R., Popescu A.C., Balanescu S.M. Inflammation as A Precursor of Atherothrombosis, Diabetes and Early Vascular Aging. Int J Mol Sci. 2022;23(2):963. doi: 10.3390/ijms23020963.
19. Koshelskaya O.A., Suslova T.E., Kologrivova I.V., Margolis N.Yu., Zhuravleva O.A., Kharitonova O.A., Kravchenko E.S., Vinnitskaya I.V., Karpov R.S. Epicardial fat thickness and biomarkers of inflammation in patients with stable coronary artery disease: correlation with the severity of coronary atherosclerosis. Russian Journal of Cardiology. 2019;(4):20-26. doi:10.15829/1560-4071-2019-4-20-26 (In Russian)
20. Evstifeeva S.E., Shalnova S.A., Kutsenko V.A., Yarovaya E.B., Balanova Yu. A., Imaeva A. E., Kapustina A. V., Muromtseva G. A., Maksimov S. A., Karamnova N.S., Samokhina Yu. Yu., Drapkina O. M., Kulakova N. V., Trubacheva I.A., Efanov A. Yu., Shabunova A.A., Belova O.A., Rotar O.P. on behalf of the ESSE-RF researchers. Association of high-sensitivity C-reactive protein with fatal and non-fatal cardiovascular events in working-age people: data from the ESSE-RF study. Russian Journal of Cardiology. 2021;26(5):4399. doi:10.15829/1560-4071-2021-4399 (In Russian)
21. Verma S.K., Garikipati V.N.S., Krishnamurthy P., Schumacher S.M., Grisanti L.A., Cimini M., heng Z., Khan M., Yue Y., Benedict C., Truongcao M.M., Rabinowitz J.E., Goukassian D.A., Tilley D., Koch W.J., Kishore R. Interleukin-10 Inhibits Bone Marrow Fibroblast Progenitor Cell-Mediated Cardiac Fibrosis in Pressure-Overloaded Myocardium. Circulation. 2017;136(10):940–53. doi: 10.1161/CIRCULATIONAHA.117.027889.
22. Kologrivova I.V., Suslova T.E., Koshelskaya O.A., Rebenkova M.S., Kharitonova O.A., Dymbrylova O.N., Andreev S.L. Macrophages in epicardial adipose tissue and serum NT-proBNP in patients with stable coronary artery disease. Medical Immunology (Russia). 2022;24(2):389-394. doi:10.15789/0000-0003-4049-8715 (In Russ.).
23. Nyawo T.A., Dludla P.V., Mazibuko-Mbeje S.E., Mthembu S.X.H., Nyambuya T.M., Nkambule B.B., Sadie-Van Gijsen H., Strijdom H., Pheiffer C. A systematic review exploring the significance of measuring epicardial fat thickness in correlation to B-type natriuretic peptide levels as prognostic and diagnostic markers in patients with or at risk of heart failure. Heart Fail Rev. 2022;27(2):665-675. doi: 10.1007/s10741-021-10160-3.
24. Mishra R.K., Beatty A.L., Jaganath R., Regan M., Wu A.H., Whooley M.A. B-type natriuretic peptides for the prediction of cardiovascular events in patients with stable coronary heart disease: the Heart and Soul Study.
25. Journal of the American Heart Association. 2014;3(4):e000907. doi: 10.1161/JAHA.114.000907.
26. Chaulin A.M., Duplyakov D.V. Increased natriuretic peptides not associated with heart failure. Russian Journal of Cardiology. 2020;25(4S):4140. doi:10.15829/1560-4071-2020-4140 (In Russian)
27. Gevorgyan M.M., Voronina N.P., Goncharova N.V., Kozaruk T.V., Russkikh G.S., Bogdanova L.A., Korolenko T.A. Cystatin C as a Marker of Progressing Cardiovascular Events during Coronary Heart Disease. Bulletin of Experimental Biology and Medicine. 2017;162(4):421-424. doi: 10.1007/s10517-017-3630-4.